Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic…
Roche announced that the US Food and Drug Administration (FDA) has approved Venclexta (venetoclax) in combination with Gazyva (obinutuzumab) for the treatment of people with previously…
Read More...
Read More...
